JMP Securities Boosts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $10.00

Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its price target hoisted by JMP Securities from $8.00 to $10.00 in a research report report published on Friday, Benzinga reports. They currently have an outperform rating on the stock. Separately, HC Wainwright boosted their target price on shares of Aquestive Therapeutics from $7.00 to $9.00 and gave […]

Leave a Reply

Your email address will not be published.

Previous post Align Technology (NASDAQ:ALGN) Given New $350.00 Price Target at Stifel Nicolaus
Next post Chatham Lodging Trust (NYSE:CLDT) Sees Large Increase in Short Interest